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Children with tuberous sclerosis complex, Sturge-Weber syndrome, and Rasmussen
encephalitis all have complex but differing needs in the process of transition/transfer
to adult care. All threemay be associated with long-term normal intelligence or a vary-
ing degree of intellectual disability. In tuberous sclerosis complex, the emphasis of care
in adulthood shifts from seizure control and developmental issues to renal and psychi-
atric disease and other issues. In Sturge-Weber syndrome, the emphasis shifts from
seizure control and rehabilitation to management of disability and migraine. In Ras-
mussen encephalitis, transition may be particularly complex for those with adolescent
onset. Those successfully operated on for childhood onset have a static problem and
the potential to dowell in life.
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As with other pediatric epilepsies, the transition into
adulthood for individuals with tuberous sclerosis complex
(TSC), Sturge-Weber syndrome (SWS), and Rasmussen
encephalitis (RE) has similar and also distinct issues. This
article summarizes the medical and social needs of individu-
als with these three disorders.
Tuberous Sclerosis Complex
TSC is a genetic disorder that affects most organ systems,
most commonly the brain and the skin, and is currently
thought to affect one out of 6,000 individuals worldwide.1
TSC is diagnosed according to clinical criteria,2 and a muta-
tion in either the TSC1 or TSC2 gene can be identified in at
least 85% of affected individuals. Broad phenotypic vari-
ability can result from mutations in both the TSC1 and TSC2
genes, including within a family carrying the same muta-
tion. Gender plays a role in TSC, as several manifestations,
particularly pulmonary involvement and lymphangiolei-
omyomatosis (LAM), occur much more frequently in
women with TSC.
The TSC gene products are components of the mamma-
lian target of rapamycin (mTOR) signaling pathway.1
Identification of this led to preclinical and clinical trials
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with mTOR inhibitors in the treatment of symptoms associ-
ated with TSC, including renal angiomyolipoma (AML),
subependymal malignant cell astrocytoma (SEGA), and
LAM. One of these compounds, everolimus, has been
approved by the U.S. Food and Drug Administration (FDA)
to treat TSC-related AML and SEGA.
Brain involvement occurs in approximately 95% of indi-
viduals with TSC, and symptoms can affect an individual
throughout their lifetime. Ninety percent of individuals with
TSC have epilepsy at some time during their life; for 70%,
onset is in the first year of life. One third of children with
TSC develop infantile spasms (IS), and two thirds of indi-
viduals with TSC develop medically refractory epilepsy.
The onset of epilepsy during adolescence and adulthood is
uncommon, but may occur. It is important to note that many
individuals with TSC experience remission of their epi-
lepsy, and are often able to taper off medications.3
Half of individuals with TSC have some degree of intel-
lectual disability (ID), which may be severe; 50% have nor-
mal cognition. Autism spectrum disorders (ASDs) occur in
approximately 40% of individuals with TSC. A history of IS
and refractory epilepsy, as well as a mutation in the TSC2
gene, are risk factors for both ID and ASD in TSC. Mental
health issues occur in 66% of individuals with TSC, and are
seen in both children and adults. Anxiety and obsessive–
compulsive tendencies are common, and can be can cause
considerable impairment for the individual.
TSC is a multisystem disorder, and age plays a role in the
various organ involvement.3 For example, cardiac rhabd-
omyoma is seen during infancy and early childhood and
typically regresses; SEGA develops during childhood and
adolescence and for unknown reasons loses the propensity
to develop in early adulthood; renal AML, although
occasionally the cause of morbidity in childhood, becomes
a more significant issue during adulthood; and pulmonary
lymphangioleiomyomatosis (LAM), which is thought to
develop sometime post puberty.
Therefore, as individuals with TSC transition from child-
hood and adolescence into adulthood, many medical issues
and concerns change, not only neurologic symptoms, but
also many other aspects of the disorder.
As that transition occurs, the “medical team” caring for
the individual also changes, and this poses similar issues
and concerns as for many of the epilepsy-related disorders
discussed in this supplement. The “adult medicine world”
may be less aware and familiar with TSC. For families of
individuals with IDs, the “adult medicine world” can also be
perceived as less family oriented than their pediatric care
teams. For most patients with TSC and IDs, independent liv-
ing is not possible and they require varying degrees of sup-
port. Many are unable to advocate for themselves.
As an individual with TSC transitions into adulthood,
many of the medical issues change. Although seizures and
IDs may persist, renal and/or pulmonary issues may become
more important, and may pose risks of significant morbidity
and occasionally mortality. Dermatologic concerns usually
persist and may become more important due to facial angio-
fibroma and periungal fibroma. The psychological and
behavioral concerns, although often present in childhood,
may appear, persist, or become more significant during
adulthood.
During childhood, the major focus of attention and con-
cern usually relates to the neurologic symptoms of TSC,
particularly on epilepsy—identifying, treating, and control-
ling the often medically refractory seizures. The child’s
development should be a focus—including language and
motor development and school performance. Other features
of potential concern include cardiac rhabdomyoma, renal
involvement, and skin features.
However, as the individual transitions to adulthood, the
focus shifts. Mental health issues have a huge impact on the
ability of many adults to function, and often are undiag-
nosed and untreated. Kidney and lung involvement often
become major medical concerns, and are probably the main
cause of TSC-related morbidity and mortality in adults.
The published literature does not critically address the
benefits of comprehensive clinics for TSC, which admit-
tedly may be expensive. However, it seems intuitively cor-
rect that to provide optimal medical care to individuals with
TSC throughout their lifetime, TSC needs to be recognized
as a complex disorder that affects the brain and also most
organs and organ systems. As individuals with TSC transi-
tion into adulthood, ideally their care could transition to
multidisciplinary specialty clinics designed to provide com-
prehensive care to adults with TSC. However, operating and
maintaining these programs is expensive in costs and
resources. It is unlikely that these services would be widely
available to adults with TSC.
Care for individuals with TSC during the transition to
adulthood would be improved by increased awareness of
possible manifestations of TSC during the lifespan. This
would particularly include those manifestations with possi-
ble significant morbidity, such as renal, lung, and mental
health issues. Therefore, for adults with TSC, the “target
Key Points
 In tuberous sclerosis complex, care issues tend to
evolve from seizure control and development in child-
hood to renal and psychiatric disease in adulthood.
 In Sturge-Weber syndrome, care issues tend evolve
from seizure control and rehabilitation to management
of disability and migraine in adulthood.
 In Rasmussen encephalitis, adolescent onset is particu-
larly complex. Those with childhood onset who suc-
cessfully underwent hemispherotomy may have better
potential to be successful in adult life.
 The process of transition/transfer should ensure that
these evolving concerns are addressed.
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audience” for increased awareness includes neurologists as
well as nephrologists, urologists, pulmonologists, and psy-
chiatrists.
Many adults with TSC will not be able to be completely
independent due to their intellectual disabilities or mental
health issues. Therefore, it would also be ideal to have clin-
ics that are able to follow individuals throughout the life-
span. Alternatively, “transition programs” could help the
individual with TSC move from pediatric care to adult-ori-
ented care. For this population of individuals with TSC,
adult care providers need knowledge of the potential medi-
cal issues of TSC as well as principles of care for individuals
with ID. Furthermore, support is needed for the family and
care providers to help navigate many life changes, including
the process of obtaining guardianship, setting up trust funds,
and investigating residential living options. The family also
changes with time, as parents of the individual with TSC
and ID become fatigued by providing intense care to their
child over the years, and their own medical issues often
become more significant. And a major source of stress for
the family, particularly the parents of the individual with
TSC and ID, is what will happen if their child “outlives”
them.
Ideally, care regarding the mental health issues will
become proactive with behavioral and mental health screens
as part of clinical care for both children and adults with
TSC. Recognizing these issues is important, as they impact
not only an individual’s daily life function, but also have a
significant effect on aspects of their medical care.
Sturge-Weber Syndrome
Sturge-Weber syndrome (SWS) is a neurocutaneous dis-
order characterized by facial port-wine stain, leptomeninge-
al angioma, intracranial calcifications, and glaucoma.
Neurologic signs and symptoms include seizures, mental
retardation, focal neurologic signs (e.g., hemiparesis,
hemianopsia), and headaches. The pathophysiology of SWS
is poorly understood. The anomalous venous plexus over
the cerebral surface likely impairs cortical drainage and
causes venous stasis and cortical dysfunction. The etiology
appears to be a somatic mutation inGNAQ.4
Transitioning SWS into adult clinics and integrating them
into society has been little discussed in the literature, but it
is important to consider, since most patients with SWS live
well into adulthood. In one study of 55 SWS patients,5 epi-
lepsy, hemiparesis, mental retardation and ocular problems
were the most frequent and severe features. The major
impediments toward a successful integration into adult soci-
ety (i.e., gainful employment, quality of life) were limited
intelligence, poor social skills, poor aesthetic appearance
due to the facial angioma, and poor seizure control.
Although cerebral lesions followed a progressive course
during early childhood, a plateau was eventually reached
and the patient was stabilized. Stabilization of the lesion
with time in SWS is consistent with our studies that show
early demise of the affected hemisphere is associated with
better cognitive function because it forces reorganization in
the contralateral hemisphere when developmental plasticity
is at a maximum.6
The Sturge-Weber Foundation database contains >5,000
patients (>2,600 adults) from 92 countries and is an invalu-
able resource to address important questions. One such early
study performed on adults (n = 52; ages 18–63 years),
found that 39% were financially self-sufficient, and 55%
were either married or were marriage “eligible.” Ten of the
52 respondents produced 20 children. The distribution of
port-wine stains included facial (98%) and extracranial
(52%). Glaucoma was present in 60%, seizures in 83%, and
neurologic deficit in 65%. Glaucoma could be congenital or
arise later in life. In subjects with seizures, developmental
delay was present in 43%, emotional and behavior problems
in 85%, special education requirements in 71%, and
employability in 46%. The corresponding figures for those
without seizures were 0%, 58%, 0%, and 78%, respec-
tively.7
Migraine is a common problem in adults with SWS. In an
Internet-based questionnaire completed by 104 adults with
SWS, 74 reported migraine headaches on a regular basis
(median age 25 years; range 3–64 years). Of these, 16
(22%) had been treated with triptans and two subjects had
experienced transient unilateral weakness. Triptans and pre-
ventative agents for migraine often improved quality of
life.8
In conclusion, patients with SWS are often employed
as adults, unless epilepsy and ID remain a significant
problem. In addition to improving seizure control, atten-
tion should be paid to emotional status (e.g., depression,
low self-esteem), migraine management, glaucoma
management, and improved education of society about the
disorder so that the affected individuals can be allowed to
reach their potential.
Rasmussen Encephalitis
Rasmussen encephalitis (or RE) is a rare inflammatory
disease causing progressive unilateral brain damage.9 The
two cardinal symptoms are intractable seizures, often epi-
lepsia partialis continua and recurring epileptic status, and
progressive neurologic deficits that include hemiparesis,
cognitive decline, hemianopsia, and aphasia. The manage-
ment of a patient with RE patient is demanding: (1) the diag-
nosis is based on clinical and laboratory findings, requires
an extensive differential diagnosis, and a longitudinal obser-
vation to assess the progressive nature of the disease; and
(2) the treatment of RE includes immunomodulatory treat-
ments in the attempt to slow down the hemispheric damage
and the associated functional decline; however, in most
cases only surgical exclusion of the affected hemisphere
offers a high chance of seizure freedom though at the price




of irreversible neurological deficits.10 The constellation of
symptoms, the progressive course of the disease, and the
lack of an effective and safe treatment severely impact the
patient’s and family’s life well beyond the epilepsy itself.
RE, in its typical presentation, manifests in childhood,
but early and late variants with different disease courses, are
reported. Adolescent or early adult onset RE represents
about 10% of all cases. Compared with typical RE, the late
form differs by a more insidious onset and slower progres-
sion of motor and mental deficits, which partly preserves
the quality of life.
There are two different scenarios when patients with RE
are considered for transition to adult care: childhood onset
and adolescence onset. For both, adolescence represents a
critical time in which RE patients are undergoing many
changes in their life that produce several personal and famil-
ial challenges. At this epoch, care should address the medi-
cal, psychosocial, and educational needs of adolescents, and
prepare patients and their families to live with a chronic dis-
ability. The following observations are based on our experi-
ence (authors TG and SM) with 21 patients older than 14
(present mean age 23 years, range 14–39 years), selected
among the 27 patients observed at the National Neurologi-
cal Institute, Milan, Italy, and collected in the context of the
LICE (Italian League Against Epilepsy) collaborative study
group on RE.
Childhood-onset RE
An adolescent with childhood-onset RE in most cases
has already had successful surgery. At the time of adoles-
cence, the neurologic issues have been overcome and the
quality of life is potentially good: Patients are seizure- and
drug-free, often remarkably, and the hemiparesis resulting
from surgery is usually stable. The main issues relate to the
acceptance of the motor disability by the individual with
RE, and by their peers, as well as the impact on developing
relationships. This is the time in which the patient fully
realizes her or his infirmity, and the disparity from peers.
Almost invariably the patient’s self-confidence decreases
and depressive symptoms appear in the form of social
withdrawal, self-marginalization, anxiety disorders, or
frank aggressive behavior against parents and doctors who
made the decision to perform the hemispherotomy. Care
should focus on these psychological issues: The patient
needs to be supported by the family, and the family often
also needs support. The treating physician should optimize
awareness (for the patient and the family) of the history of
the disease and of the unavoidability of the therapeutic
choice. In our experience, inclusion of individuals with RE
in structured social networks (e.g., scouting, or other vol-
unteer groups) provides a way to increase diversity and
identification of peer groups, and helps them to improve
self-acceptance.
A minority of RE patients have an outcome postsurgery
that is nonoptimal. In this scenario, the main issues are
similarly related to the hemiparesis, mental deficits, neuro-
psychological disabilities, and behavioral disorders—all
problems that were present to some degree before the sur-
gery but may be more profound after surgery. In addition,
there are persistent seizures. At the time of adolescence,
these patients may be poorly aware of the disease and have a
reduced ability to comprehend their disability. The burden
of the disease is mainly on the family, and there is a risk of
social maladjustment. Indeed, the ID and the behavior
problems, including aggressiveness, impulsivity, lack of
inhibition, and iterative behaviors, may lead to social exclu-
sion. To approach these problems, psychiatric help, that
might include drug treatment, is often important. The family
should be supported and the patient integrated into a trained
social network, including school and employment in
protected and aware environments. Finally, there is a small
subset of patients with severe disabilities resulting from
unsuccessful or complicated surgical treatment. In these
patients who need continuous assistance, the major issues
are those of any severe encephalopathy: It is important to
underscore the need for social and economic help as well as
for respite care for the entire family.
Adolescence-onset RE
In most cases the diagnosis is more difficult because the
clinical course is less severe and more protracted. It may
take months or years before the definitive diagnosis can be
made. The slow progression of the disease together with the
reported efficacy of immunomodulatory therapy make treat-
ment decisions highly challenging, particularly when the
dominant hemisphere is affected. The motor impairment is
usually mild, and hemispherectomy is considered the last
resort. The management of an RE adolescent, who, com-
pared to a child, has a better comprehension of the disease,
might focus on the issues related to the impact of the sei-
zures and motor deficits on a person whose body (and mind)
is quickly changing and who is more independent and expe-
riencing his or her first emotional relationships. The rarity
of the disease (which implies an experience of loneliness),
the progression of symptoms (which implies anxiety for the
future), the constellation of potentially disabling symptoms,
and the uncertainty about prognosis are stressful for the
patient, family, and treating physician. To address all these
concerns, the physician’s first step is to “budget” adequate
time to understand what the patient is able/wants to know. It
is mandatory to establish an “alliance” with the patient and
the family, to communicate about increasing concerns, and
to actively engage the patient in the treatment decision. In
this process, psychological support may be needed. Finally,
it is worth noting that the complexity of diagnostic and
therapeutic workup requires multidisciplinary expertise and
that many decisions need to be shared by the professional
team.
Transition from pediatric to adult care in all the Ital-
ian RE patients did not take place. Follow-up was some-
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times with the same physician who provided care for
the patient during childhood. In most cases there was an
agreement between physician and family (and patient) to
remain under pediatric care, because of the long-lasting
history of care and decisions taken together and the
close “alliance” with affective linkage built over time.
In most cases the patients with nonoptimal outcome and
those requiring medical assistance are also still cared for
by the primary pediatric neurologist. Reasons for this
lack of transition/transfer were the supposed poor exper-
tise about this rare and complex disease among most
adult physicians and the reluctance of the family to
leave the pediatric environment that they perceived as
competent and attentive. The few families who were
encouraged to move to an adult health care environment
returned to the pediatric neurologic center, reporting
their disappointing experience.
For an ideal transition model, we propose that the
patients with good outcome, who indeed do not require a
neurologist, may be followed by the original case manager
or physician. In this model, the periodic medical examina-
tion would focus on an update on the quality of life with
referral to an adult specialist only in the event of new
problems. In contrast, youth with active problems that
require medical assistance should be gradually transferred
to a specialized adult care center that has the capacity to
cope with the multifaceted aspects of disability. Ideally
this center would have good partnerships with schools,
employment counseling/training facilities, and programs to
enhance leisure activities.
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